These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 3362260

  • 1. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
    von Oefele K, Grohmann R, Hippius H, Rüther E.
    Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260
    [No Abstract] [Full Text] [Related]

  • 2. Combined use of tricyclic antidepressants and monoamine oxidase inhibitors.
    Lader M.
    J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):20-4. PubMed ID: 6355073
    [Abstract] [Full Text] [Related]

  • 3. On combining TCAs and MAOIs.
    Grounds D.
    Aust N Z J Psychiatry; 1993 Jun; 27(2):344, 346. PubMed ID: 8363548
    [No Abstract] [Full Text] [Related]

  • 4. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
    Rosan TA, Mesones HL, Brengio F.
    Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
    [Abstract] [Full Text] [Related]

  • 5. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D, Silver JM, Opler LA.
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [Abstract] [Full Text] [Related]

  • 6. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP, Herbstein J, Damlouji N.
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [Abstract] [Full Text] [Related]

  • 7. Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy.
    Tiller JW, Mitchell P, Burrows GD.
    Aust N Z J Psychiatry; 1992 Jun; 26(2):327-9. PubMed ID: 1642632
    [No Abstract] [Full Text] [Related]

  • 8. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM, de Leon J.
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [Abstract] [Full Text] [Related]

  • 9. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [Abstract] [Full Text] [Related]

  • 10. [MAO inhibitors and depressive disorders today].
    Bonamy D, Olié JP, Lôo H.
    Encephale; 1983 Jul; 9(2):123-36. PubMed ID: 6641614
    [Abstract] [Full Text] [Related]

  • 11. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M, Pilhatsch M, Bauer M, Köberle U, Ricken R, Janssen G, Ulrich S, Bschor T.
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [Abstract] [Full Text] [Related]

  • 12. The treatment of depression: update 1984.
    Enowitch BI.
    Conn Med; 1984 Nov; 48(11):703-6. PubMed ID: 6391806
    [No Abstract] [Full Text] [Related]

  • 13. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death.
    Kline SS, Mauro LS, Scala-Barnett DM, Zick D.
    Clin Pharm; 1989 Jul; 8(7):510-4. PubMed ID: 2568897
    [No Abstract] [Full Text] [Related]

  • 14. Tricyclic antidepressant and monoamine oxidase inhibitor combination therapy.
    Ponto LB, Perry PJ, Liskow BI, Seaba HH.
    J Maine Med Assoc; 1977 Aug; 68(8):283-9. PubMed ID: 894133
    [No Abstract] [Full Text] [Related]

  • 15. The management of depression: a review of pharmacological and non-pharmacological treatments.
    Johnson GF, Wilson P.
    Med J Aust; 1989 Oct 02; 151(7):397-400, 403, 406. PubMed ID: 2677623
    [No Abstract] [Full Text] [Related]

  • 16. [Are monoamine oxidase inhibitors coming back?].
    Nolen WA.
    Ned Tijdschr Geneeskd; 1985 Aug 17; 129(33):1571-6. PubMed ID: 4047207
    [No Abstract] [Full Text] [Related]

  • 17. Monoamine oxidase-inhibiting antidepressants. A clinical update.
    Murphy DL, Sunderland T, Cohen RM.
    Psychiatr Clin North Am; 1984 Sep 17; 7(3):549-62. PubMed ID: 6384960
    [Abstract] [Full Text] [Related]

  • 18. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ, Sanz-Carrillo C, Ferrández Payo M.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995 Sep 17; 23(4):217-22. PubMed ID: 7484306
    [Abstract] [Full Text] [Related]

  • 19. Combined MAOI-tricylic antidepressant treatment: a controlled trial.
    White K, Razani J, Simpson G, Rebal R, Sloane RB, O'Leary J, Palmer R.
    Psychopharmacol Bull; 1982 Oct 17; 18(4):180-1. PubMed ID: 6760234
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of depressive disorders].
    Saiz Ruiz J, Ibáñez Cuadrado A.
    Rev Clin Esp; 1997 Nov 17; 197 Suppl 3():35-43. PubMed ID: 9477689
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.